Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon FacilityGlobeNewsWire • 09/30/21
Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac SurgeriesGlobeNewsWire • 09/21/21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021GlobeNewsWire • 09/15/21
Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/08/21
Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/08/21
Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare ConferenceGlobeNewsWire • 09/03/21
Pacira (PCRX) Down 1.6% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/02/21
Flexion Therapeutics Announces Inclusion of ZILRETTA® in American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines for the Management of Osteoarthritis of the KneeGlobeNewsWire • 09/02/21
Flexion Therapeutics (FLXN) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 08/30/21
Flexion Therapeutics Announces Expansion of Phase 1b Trial Investigating FX301 for the Management of Post-Operative PainGlobeNewsWire • 08/25/21
Why Flexion Therapeutics (FLXN) Could Be an Impressive Growth StockZacks Investment Research • 08/17/21
Down 24.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Flexion Therapeutics (FLXN)Zacks Investment Research • 08/16/21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021GlobeNewsWire • 08/10/21
Flexion Therapeutics Announces Publication of Results from Phase 2 Pharmacokinetics (PK) and Safety Study of ZILRETTA® in Shoulder Osteoarthritis (OA)GlobeNewsWire • 08/09/21
Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Flexion Therapeutics (FLXN) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/04/21
Flexion Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Business HighlightsGlobeNewsWire • 08/04/21
Pacira BioSciences, Inc. (PCRX) CEO Dave Stack on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021GlobeNewsWire • 08/03/21
Flexion Therapeutics to Report Second-Quarter 2021 Financial Results on August 4, 2021GlobeNewsWire • 07/29/21